No Yes Ok

Archive

EQT Life Sciences Company News Tuesday, September 13th, 2022
ONWARD Reports Positive Topline Results from a Pivotal Study to Restore Arm and Hand Function in People with Spinal Cord Injury   Up-LIFT study achieves primary endpoint: Statistically significant and clinica [...]
EQT Life Sciences leads $20 Million Financing Round in FundamentalVR Thursday, August 11th, 2022
FundamentalVR receives Series B growth investments to disrupt the medical simulation market – expected to be worth $4.2 billion by 2025.   Amsterdam, the Netherlands, August 11, 2022 – FundamentalVR has r [...]
EQT Life Sciences announces its portfolio company NewAmsterdam Pharma going public Monday, July 25th, 2022
Leading institutional investors commit $235 million through an oversubscribed and upsized private investment in public equity (“PIPE”) led by Frazier Healthcare Partners and Bain Capital Life Sciences  [...]
EQT Life Sciences Announces Strategic Alliance of its Portfolio Company iStar Medical with AbbVie Wednesday, July 20th, 2022
Alliance will provide opportunity for AbbVie to further expand its diverse eye care portfolio and provide additional treatment options for glaucoma patients Collaboration further supports the role of MINIjec [...]
EQT Life Sciences Announces Launch and Series A Financing Round Friday, June 10th, 2022
of Portfolio Company Ariceum Therapeutics   Oversubscribed financing co-led by HealthCap and EQT Life Sciences (formerly LSP); joined by Pureos Bioventures Developing novel drugs for systemic target [...]
EQT Life Sciences Announces Series D Financing Round Tuesday, May 24th, 2022
of Portfolio Company Vivasure   Funds will support clinical development and regulatory approval of fully absorbable percutaneous closure devices for large-bore vessels   Amsterdam, the Netherlands [...]
LSP’s acquisition by EQT completed; LSP renamed to EQT Life Sciences Tuesday, March 1st, 2022
Amsterdam, March 1, 2022 — LSP, the European life sciences and healthcare investment firm, today announced that the closing of it’s acquisition by EQT took place on February 28, 2022. Henceforth, LSP will be cal [...]
LSP closes EUR 1 billion flagship fund LSP 7 to invest in life sciences companies Friday, February 11th, 2022
Amsterdam, 11 February 2022 — LSP announced today that it has raised over EUR 1 billion for its flagship fund LSP 7. This constitutes the final close of the largest life sciences venture capital fund ever raised in [...]
LSP leads €22.5 million ($25 million) Series A in Irish medical device company Perfuze Wednesday, February 9th, 2022
Perfuze develops catheter-based technology for treating acute ischemic stroke Financing was led by new investors LSP and Seroba Life Sciences and joined by new investor SV Health and existing investors   [...]
LSP invests in the €13 million financing round of silver tech company Nobi Thursday, January 27th, 2022
to support its international expansion   Amsterdam, The Netherlands, 27 January 2022 – LSP today announced that Nobi, a Belgian company commercializing a smart lamp allowing superior fall detection and fall [...]


2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
back to archive overview
Follow us

No Yes Ok

Archive

EQT Life Sciences Company News Tuesday, September 13th, 2022
ONWARD Reports Positive Topline Results from a Pivotal Study to Restore Arm and Hand Function in People with Spinal Cord Injury   Up-LIFT study achieves primary endpoint: Statistically significant and clinica [...]
EQT Life Sciences leads $20 Million Financing Round in FundamentalVR Thursday, August 11th, 2022
FundamentalVR receives Series B growth investments to disrupt the medical simulation market – expected to be worth $4.2 billion by 2025.   Amsterdam, the Netherlands, August 11, 2022 – FundamentalVR has r [...]
EQT Life Sciences announces its portfolio company NewAmsterdam Pharma going public Monday, July 25th, 2022
Leading institutional investors commit $235 million through an oversubscribed and upsized private investment in public equity (“PIPE”) led by Frazier Healthcare Partners and Bain Capital Life Sciences  [...]
EQT Life Sciences Announces Strategic Alliance of its Portfolio Company iStar Medical with AbbVie Wednesday, July 20th, 2022
Alliance will provide opportunity for AbbVie to further expand its diverse eye care portfolio and provide additional treatment options for glaucoma patients Collaboration further supports the role of MINIjec [...]
EQT Life Sciences Announces Launch and Series A Financing Round Friday, June 10th, 2022
of Portfolio Company Ariceum Therapeutics   Oversubscribed financing co-led by HealthCap and EQT Life Sciences (formerly LSP); joined by Pureos Bioventures Developing novel drugs for systemic target [...]
EQT Life Sciences Announces Series D Financing Round Tuesday, May 24th, 2022
of Portfolio Company Vivasure   Funds will support clinical development and regulatory approval of fully absorbable percutaneous closure devices for large-bore vessels   Amsterdam, the Netherlands [...]
LSP’s acquisition by EQT completed; LSP renamed to EQT Life Sciences Tuesday, March 1st, 2022
Amsterdam, March 1, 2022 — LSP, the European life sciences and healthcare investment firm, today announced that the closing of it’s acquisition by EQT took place on February 28, 2022. Henceforth, LSP will be cal [...]
LSP closes EUR 1 billion flagship fund LSP 7 to invest in life sciences companies Friday, February 11th, 2022
Amsterdam, 11 February 2022 — LSP announced today that it has raised over EUR 1 billion for its flagship fund LSP 7. This constitutes the final close of the largest life sciences venture capital fund ever raised in [...]
LSP leads €22.5 million ($25 million) Series A in Irish medical device company Perfuze Wednesday, February 9th, 2022
Perfuze develops catheter-based technology for treating acute ischemic stroke Financing was led by new investors LSP and Seroba Life Sciences and joined by new investor SV Health and existing investors   [...]
LSP invests in the €13 million financing round of silver tech company Nobi Thursday, January 27th, 2022
to support its international expansion   Amsterdam, The Netherlands, 27 January 2022 – LSP today announced that Nobi, a Belgian company commercializing a smart lamp allowing superior fall detection and fall [...]


2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
back to archive overview
X

MONTHLY REPORTS

Here you can subscribe for the monthly report of the LSP Life Sciences Fund